With over 15 years of expertise in developing injectable and liquid pharmaceutical forms, CARBOGEN AMCIS’ Saint-Beauzire site provides tailored solutions for pre-clinical and clinical trials and small ...
Bristol Myers (BMY) announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval ...
Bioconjugation presents an new frontier for pharmaceutical development, providing an option for improved drug efficacy across ...
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the ...
She said focus area of the partnership for her country includes drugs regulations, indigenous manufacturing of active ...
Vertex Pharmaceuticals, a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and conditions, has announced that the ...
AbbVie announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the approval of upadacitinib (Rinvoq; 15 mg, once ...
The contract will support R&D of high-quality APIs for substance use disorders and mental health conditions, starting with synthesis and scale-up of psilocybin, which is derived from mushrooms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback